Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inspire Medical Systems (INSP) Equity Average (2018 - 2025)

Historic Equity Average for Inspire Medical Systems (INSP) over the last 8 years, with Q4 2025 value amounting to $723.8 million.

  • Inspire Medical Systems' Equity Average rose 442.65% to $723.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $723.8 million, marking a year-over-year increase of 442.65%. This contributed to the annual value of $735.4 million for FY2025, which is 1653.02% up from last year.
  • Inspire Medical Systems' Equity Average amounted to $723.8 million in Q4 2025, which was up 442.65% from $672.1 million recorded in Q3 2025.
  • Inspire Medical Systems' 5-year Equity Average high stood at $723.8 million for Q4 2025, and its period low was $220.1 million during Q3 2021.
  • Its 5-year average for Equity Average is $478.0 million, with a median of $526.9 million in 2023.
  • As far as peak fluctuations go, Inspire Medical Systems' Equity Average tumbled by 480.15% in 2021, and later surged by 12874.29% in 2023.
  • Over the past 5 years, Inspire Medical Systems' Equity Average (Quarter) stood at $224.7 million in 2021, then soared by 115.03% to $483.1 million in 2022, then rose by 15.57% to $558.3 million in 2023, then rose by 24.14% to $693.1 million in 2024, then grew by 4.43% to $723.8 million in 2025.
  • Its Equity Average stands at $723.8 million for Q4 2025, versus $672.1 million for Q3 2025 and $656.8 million for Q2 2025.